This ASCO publication features, AYA Sarcoma Director, David Shulman, MD, who describes how a blood test can spot targetable genomic alterations in adolescents and young adults with advanced solid tumors. @danafarber.bsky.social @danafarbernews.bsky.social dailynews.ascopubs.org/do/gain-anal...

This year, an estimated 17,370 people in the U.S. will be diagnosed with sarcoma, according to @americancancersoc.bsky.social.   Our healing garden glowed yellow this July for Sarcoma Awareness Month to honor everyone impacted by the disease and help raise awareness. 🎗️ @dfciayasarcoma.bsky.social

In honor of #SarcomaAwarenessMonth, Suzanne George, MD, discusses @danafarber.bsky.social’s relentless efforts to promote early detection and support ongoing research to improve the lives of patients living with these rare cancers including #GIST. Watch here: bit.ly/4vI65mM

Sarcoma Awareness and Advances: Suzanne George, MD | Dana-Farber Cancer Institute

July is Sarcoma Awareness Month. In this video, Suzanne George, MD, a sarcoma expert at Dana-Farber Cancer Institute, discusses the importance of sarcoma awareness, early detection, and advancing research for rare cancers, including gastrointestinal stromal tumors (GIST). Learn how Dana-Farber is working to improve diagnosis, expand treatment options, and drive research that is improving outcomes for people living with sarcoma and GIST.

bit.ly

During Sarcoma Awareness Month, a young adult with Ewing sarcoma shares her experience and why the AYA-focused care provided at Dana-Farber matters. Read her story on the Insight Blog. @danafarber.bsky.social @danafarbernews.bsky.social blog.dana-farber.org/insight/2026...

Doctor by Day, Patient by Night: Young Sarcoma Survivor Overcomes Life Interrupted

From doctor to patient, one young physician shares how an Ewing sarcoma diagnosis reshaped her life, career, and perspective on cancer care.

blog.dana-farber.org

July is #SarcomaAwarenessMonth, a time to raise awareness about this rare cancer that affects connective tissues such as bone, muscle, blood vessels, nerves, and fat. Learn more about risk factors, signs and symptoms, diagnosis, and treatment options at @danafarber.bsky.social at bit.ly/4gLBznV

Sarcoma and Bone Cancer Types

Get information about soft tissue sarcomas, types of bone cancer, and other related conditions.

bit.ly

David Shulman, MD, Director of the Dana-Farber AYA Sarcoma Program, discusses a newly opened phase 1/2 trial of LNTH-2403, an LRRC15-targeted radiopharmaceutical, for relapsed/refractory osteosarcoma. @danafarber.bsky.social @danafarbernews.bsky.social www.youtube.com/watch?v=vQ1a...

OsteoBites | Phase 1/2 Study of LNTH 2403 for Relapsed Osteosarcoma

YouTube video by Osteosarcoma: MIB Agents Osteosarcoma Alliance

youtube.com

A focus group study from the DFCI AYA Sarcoma Program found that sarcoma affects adolescents and young adult patients' physical, emotional, social, and economic well-being. Earlier introduction of support services may help address some of these unmet needs.

Dana-Farber News@danafarbernews.bsky.social · 3mo ago

In this interview with @onclive.bsky.social, @danafarber.bsky.social’s Dr. Vinayak Venkataraman spotlights a focus-group study identifying mobility, autonomy, and supportive care gaps in adolescent and young adults with sarcoma. ➡️ bit.ly/4cETCbS

“We’ve demonstrated that we can successfully run trials for adolescents & young adults with sarcomas, and we're excited to have a growing portfolio of drugs and clinical trials for these diseases,” says @danafarber.bsky.social’s Dr. David Shulman. @dfciayasarcoma.bsky.social ➡️bit.ly/3RWIq3O

New Options for Adolescent and Young Adult Patients with Sarcoma 

Published: June 8, 2026Sarcomas are cancers that occur in bone or soft tissue, such as muscles and fat. These cancers are rare and diverse, with more than 150 different variations.  Treatment is advancing for some sarcomas, but most forms of the disease are still treated using chemotherapy, radiation and/or surgery. In some cases, there are few options if the cancer comes back.  Dana-Farber physician-scientists are evaluating innovative ... Read more

bit.ly

Welcome to the official account of the Dana-Farber Adolescent & Young Adult (AYA) Sarcoma Program! We look forward to sharing content as we advance care for AYAs with sarcoma through clinical expertise, translational research and patient engagement @danafarber.bsky.social @danafarbernews.bsky.social